Drug Type Small molecule drug |
Synonyms BY 343, BY-343, BYK-33043 |
Target |
Mechanism PDE3 inhibitors(Phosphodiesterase 3 inhibitors), PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H39N3O3 |
InChIKeyCVDXFPBVOIERBH-ISIPKWIHSA-N |
CAS Registry207993-12-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | US | - | |
Asthma | Phase 2 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | EU | - | - |
Pulmonary Disease, Chronic Obstructive | Phase 2 | - | - | |
Psoriasis | Phase 1 | EU | - | - |